Your gateway to a free society
Article
U.S. ‘No Fly List’ Leaks After Being Left in an Unsecured Airline Server

U.S. ‘No Fly List’ Leaks After Being Left in an Unsecured Airline Server

The list, which was discovered by a Swiss hacker, contains names and birth dates and over 1 million entries.
A copy of the U.S. No Fly List has leaked after being stored on an unsecure server connected to a commercial airline. The No Fly List is an official list maintained by the U.S. government of people it has banned from traveling in or out of the United States on commercial flights.
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Feb 14, 2026 / Tyler Durden
FAA Mandates Airlines To Affirm Merit Hiring For Pilots
FAA Mandates Airlines To Affirm Merit Hiring For Pilots Authored by Naveen Athrappully via The Epoch Times, The Federal Aviation Administration (FAA) is issuing a new mandatory rule that requires all commercial airlines in the country to formally commit to merit-based hiring for pilots, according to a Feb. 13 statement from the Department of Transportation (DOT). Under the new mandate, all U.S. carriers must certify that the practice of airlines hiring based on race and sex has ended or face a federal investigation. “When families board their aircraft, they should fly with confidence...
Read more
Shane Cashman
ELIZA BLEU AND THE PERPETUAL TRAUMA MACHINE—PART 2
Feb 24, 2026 / Tyler Durden
Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs
Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs Novo Nordisk shares in Copenhagen can't catch a bid. The liquidation is accelerating again after a Bloomberg headline on Tuesday morning: the Danish drugmaker will slash U.S. list prices for Wegovy and Ozempic next year. The move suggests that the new CEO is pursuing market share amid intensifying competition in the GLP-1 space. Jamey Millar, Novo's head of U.S. operations, was quoted by Bloomberg as saying the company set a monthly price of $675 for its family of semaglutide drugs,...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.